Legislative reports

The Oregon Prescription Drug Affordability Board approved 2025 PDAB Drug Review Report for sending to the Oregon Legislature in accordance with ORS 646A.697. The report includes:

• Overview of the 2025 review process
  
• Subset list of drug and insulin products reviewed in 2025
  
• Product-specific cost and affordability determination for Cosentyx, Trulicity, Vraylar, Lantus SoloStar
  
• Recommendations
  


ARCHIVED Legislative reports: Annual reports are archived to conform with the rule on digital accessibility under Americans with Disabilities Act. Archived reports are: 1. Created before April 26, 2027; 2. Retained exclusively for reference, research, or recordkeeping; 3. Unaltered after the date of archiving; 4. Organized and stored in a dedicated area clearly identified as being archived.

View 2025 Drug Review Report